File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1111/irv.12798
- Scopus: eid_2-s2.0-85089785716
- PMID: 32844604
- WOS: WOS:000562357700001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Human post‐infection serological response to the spike and nucleocapsid proteins of SARS‐CoV‐2
Title | Human post‐infection serological response to the spike and nucleocapsid proteins of SARS‐CoV‐2 |
---|---|
Authors | |
Keywords | antibodies epidemiology nucleocapsid SARS‐CoV‐2 serology |
Issue Date | 2021 |
Publisher | Wiley Open Access. The Journal's web site is located at http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1750-2659 |
Citation | Influenza and Other Respiratory Viruses, 2021, v. 15 n. 1, p. 7-12 How to Cite? |
Abstract | To inform seroepidemiological studies, we characterized the IgG‐ responses in COVID‐19 patients against the two major SARS‐CoV‐2 viral proteins, spike (S) and nucleocapsid (N). We tested 70 COVID‐19 sera collected up to 85 days post‐symptom onset and 230 non‐COVID‐19 sera, including 27 SARS sera from 2003. Although the average SARS‐CoV‐2 S and N‐IgG titers were comparable, N‐responses were more variable among individuals. S‐ and N‐assay specificity tested with non‐COVID‐19 sera were comparable at 97.5% and 97.0%, respectively. Therefore, S will make a better target due to its lower cross‐reactive potential and its' more consistent frequency of detection compared to N. |
Persistent Identifier | http://hdl.handle.net/10722/290824 |
ISSN | 2023 Impact Factor: 4.3 2023 SCImago Journal Rankings: 1.485 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Xiao, C | - |
dc.contributor.author | Ling, S | - |
dc.contributor.author | Qiu, M | - |
dc.contributor.author | Deng, Z | - |
dc.contributor.author | Chen, L | - |
dc.contributor.author | Zhu, A | - |
dc.contributor.author | Chen, Y | - |
dc.contributor.author | Liu, Y | - |
dc.contributor.author | Lin, X | - |
dc.contributor.author | Lin, F | - |
dc.contributor.author | Wu, Q | - |
dc.contributor.author | Shen, L | - |
dc.contributor.author | Ye, F | - |
dc.contributor.author | Liu, X | - |
dc.contributor.author | Li, Y | - |
dc.contributor.author | Zhao, J | - |
dc.contributor.author | Yang, Z | - |
dc.contributor.author | Cowling, BJ | - |
dc.contributor.author | Webby, R | - |
dc.contributor.author | Zanin, M | - |
dc.contributor.author | Wong, SS | - |
dc.date.accessioned | 2020-11-02T05:47:39Z | - |
dc.date.available | 2020-11-02T05:47:39Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | Influenza and Other Respiratory Viruses, 2021, v. 15 n. 1, p. 7-12 | - |
dc.identifier.issn | 1750-2640 | - |
dc.identifier.uri | http://hdl.handle.net/10722/290824 | - |
dc.description.abstract | To inform seroepidemiological studies, we characterized the IgG‐ responses in COVID‐19 patients against the two major SARS‐CoV‐2 viral proteins, spike (S) and nucleocapsid (N). We tested 70 COVID‐19 sera collected up to 85 days post‐symptom onset and 230 non‐COVID‐19 sera, including 27 SARS sera from 2003. Although the average SARS‐CoV‐2 S and N‐IgG titers were comparable, N‐responses were more variable among individuals. S‐ and N‐assay specificity tested with non‐COVID‐19 sera were comparable at 97.5% and 97.0%, respectively. Therefore, S will make a better target due to its lower cross‐reactive potential and its' more consistent frequency of detection compared to N. | - |
dc.language | eng | - |
dc.publisher | Wiley Open Access. The Journal's web site is located at http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1750-2659 | - |
dc.relation.ispartof | Influenza and Other Respiratory Viruses | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | antibodies | - |
dc.subject | epidemiology | - |
dc.subject | nucleocapsid | - |
dc.subject | SARS‐CoV‐2 | - |
dc.subject | serology | - |
dc.title | Human post‐infection serological response to the spike and nucleocapsid proteins of SARS‐CoV‐2 | - |
dc.type | Article | - |
dc.identifier.email | Cowling, BJ: bcowling@hku.hk | - |
dc.identifier.authority | Cowling, BJ=rp01326 | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.1111/irv.12798 | - |
dc.identifier.pmid | 32844604 | - |
dc.identifier.pmcid | PMC7461388 | - |
dc.identifier.scopus | eid_2-s2.0-85089785716 | - |
dc.identifier.hkuros | 318566 | - |
dc.identifier.volume | 15 | - |
dc.identifier.issue | 1 | - |
dc.identifier.spage | 7 | - |
dc.identifier.epage | 12 | - |
dc.identifier.isi | WOS:000562357700001 | - |
dc.publisher.place | United Kingdom | - |
dc.identifier.issnl | 1750-2640 | - |